Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Incyte Corporation
Incyte Corporation
University of Alabama at Birmingham
National Cancer Institute (NCI)
Incyte Corporation
Incyte Corporation
University of Rochester
Merck Sharp & Dohme LLC
Prelude Therapeutics
University of Southern California
City of Hope Medical Center
Incyte Corporation
University Hospital, Brest
Icahn School of Medicine at Mount Sinai
Center for International Blood and Marrow Transplant Research
University of Washington
Incyte Corporation
Masonic Cancer Center, University of Minnesota
University of California, Irvine
City of Hope Medical Center
Disc Medicine, Inc
University Hospital, Angers
Fred Hutchinson Cancer Center
Azienda Ospedaliero-Universitaria di Parma
MPN Research Foundation
Icahn School of Medicine at Mount Sinai
M.D. Anderson Cancer Center
University of Chicago
Icahn School of Medicine at Mount Sinai
University Hospital, Angers
Thomas Jefferson University
Massive Bio, Inc.
UNC Lineberger Comprehensive Cancer Center
Mayo Clinic
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Ryvu Therapeutics SA
Hangzhou GluBio Pharmaceutical Co., Ltd.
PharmaEssentia
University Hospital, Bordeaux
Barbara Ann Karmanos Cancer Institute
Masonic Cancer Center, University of Minnesota
UNC Lineberger Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
University of Virginia
Cellenkos, Inc.
Icahn School of Medicine at Mount Sinai
University of Rochester
Epigenetix, Inc.
University Health Network, Toronto
University Hospital, Brest
Telios Pharma, Inc.